Multi-center MRD Registry for Inflammatory Breast Cancer
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Observational
SUMMARY
To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• Female or males ≥18 years of age with the ability to understand and sign a written
• Participants who have a clinical diagnosis of stage III or IV inflammatory breast cancer (IBC).
• Participants who are planning to have or already completed a minimum of one blood draw for Signatera testing, for which the result and clinical data can be deposited into the study database.
• Participants must be within eight months of diagnosis and have not undergone breast surgery for this diagnosis of breast cancer.
• Participants must be English-speaking.
Locations
United States
Texas
MD Anderson Cancer Center
RECRUITING
Houston
Contact Information
Primary
Sadia Saleem, MD
ssaleem@mdanderson.org
281-566-1900
Backup
Angela Alexander
aalexand@mdanderson.org
713-792-9137
Time Frame
Start Date: 2025-05-05
Estimated Completion Date: 2032-05-31
Participants
Target number of participants: 200
Treatments
Group 1
Participants will fill out a quality-of-life questionnaire and complete a MRD test.
Related Therapeutic Areas
Sponsors
Leads: M.D. Anderson Cancer Center